Back to top
more

ITAMAR MED-ADR (ITMR)

(Delayed Data from NSDQ)

$10.50 USD

10.50
300

0.00 (0.00%)

Updated May 3, 2019 03:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

[ITMR]

Reports for Purchase

Showing records 1 - 18 ( 18 total )

Industry: Medical Info Systems

Record: 1

09/14/2021

Company Report

Pages: 5

ZOLL Medical Buying Itamar Medical; Downgrade to Neutral; PT down to $31

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 2

09/13/2021

Company Report

Pages: 5

Top- and Bottom-Line In-Line; Encouraging Guidance; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 3

06/02/2021

Company Report

Pages: 5

Board Composition Evolving; Solid 1Q21 Sales Performance; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 4

03/08/2021

Company Report

Pages: 5

Record 4Q20 Revenue; Long-Term Growth Outlook Positive; Raising PT to $36

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 5

01/14/2021

Company Report

Pages: 4

Spry Health Acquisition Appears Highly Complementary; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 6

01/11/2021

Company Report

Pages: 4

Preliminary 4Q20 Revenue Numbers Beat Our Forecast; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 7

12/17/2020

Company Report

Pages: 5

WatchPAT Coverage Expansion; Reimbursement Maintained; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 8

11/18/2020

Company Report

Pages: 5

3Q20 Financials; Strong Revenue Growth; Raising PT to $30

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 9

10/02/2020

Company Report

Pages: 4

WatchPAT 300 Wins Japanese Approval; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 10

09/08/2020

Company Report

Pages: 5

Blue Cross Prior Authorization Removal Bodes Well; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 11

08/17/2020

Company Report

Pages: 5

Long-Term Growth Still Achievable; 2Q20 Financials; Raising PT to $28

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 12

05/28/2020

Company Report

Pages: 4

1Q20 Financial Results Reported; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 13

05/04/2020

Company Report

Pages: 4

WatchPAT One Receives CE Mark Designation; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 14

04/23/2020

Company Report

Pages: 4

COVID-19 Clinical Study to Be Funded; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 15

04/15/2020

Company Report

Pages: 5

Outlook Revised; Minimal Near-to-Medium-Term Impact; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 16

04/07/2020

Company Report

Pages: 4

BetterNight Partnership Announced; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 17

04/01/2020

Company Report

Pages: 4

Lunella Launch Should Broaden Digital Health Platform Reach; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical Info Systems

Record: 18

03/23/2020

Company Report

Pages: 31

Solving the Sleep Apnea Problem; Initiating at Buy and $21 PT

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 75.00

Research Provided by a Third Party